Immunohistochemical detection of p53 protein in neoplastic, preneoplastic and normal bronchial mucosa specimens obtained during diagnostic bronchoscopy

Oncology Reports

Volumn 5, Issue 3, 1998, Pages 763-769

  Orfanidou, D ^a   Kalomenidis, J ^a   Rasidakis, A ^a   Papamichalis, G ^a   Toumbis, M ^a   Labaditis, J ^a   Sacharidou, A ^a   Papastamatiou, H ^a   Jordanoglou, J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Lung cancer; Neoplastic; Normal bronchial mucosa; P53; Preneoplastic

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; BRONCHUS BIOPSY; BRONCHUS MUCOSA; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG CARCINOGENESIS; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION;

EID: 0031978315     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.3.763     Document Type: Article

References (43)

1. Beckett W: Epidemiology and etiology of lung cancer. Clin Chest Med 14: 1-16, 1993.
2. Ginsberg RJ, Kris MG and Armstrong JG: Cancer of the lung. In: Cancer, Principles and Practice of Oncology. De Vita VT, Rosenberg S and Hellman S (eds.) JB Lippincott Co., Philadelphia, pp673-723, 1993.
3. Auerbach O, Gere GB, Forman JB, et al: Changes in the bronchial epithelium in reaction to smoking and cancer of the lung. N Engl J Med 256: 97-104, 1957.
4. Vialet J and Minna JD: Dominant oncogenes and tumour suppressor genes in the pathogenesis of lung cancer. Am J Respir Cell Mol Biol 2: 225-232, 1990.
5. Fontanini G, Vignati S, Bigini D, Merlo GR, Ribecchini A, Angeletti CA, Basolo F, Pingitore R and Bevilacqua G: Human non-small cell lung cancer: p53 protein accumulation is an early event and persist during metastatic progression. J Pathol 174: 23-31, 1994.
6. Greenblatt MS, Bennett WP, Hollstein M and Harris CC: Mutations in the p53 tumour suppressor gene. Clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878, 1994.
7. Chen PL, Chen Y, Bookstain R and Lee WH: Genetic mechanism of tumour suppression by the human p53 gene. Science 250: 1576-1579, 1990.
8. Top B, Mooi W, Klaver SG, Boerrigter L, Wisman P, Elbers HR, Visser S and Rodenhuis S: Comparative analysis of p53 gene mutations and protein accumulation in human non-small-cell lung cancer. Int J Cancer 64: 83-91, 1995.
9. Chiba I, Takahashi T, Nau M, Amico D, Curiel D, Mitsudomi T, Buchhagen LD, Carbone D, Piantadosi S, Koga H, Reissman TP, Slamon JD, Holmes EC and Minna DJ: Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene 5: 1603-1610, 1990.
10. Hirano T, Franzen B, Kato H, Ebihara Y and Auer G: Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy and p53 expression. Am J Pathol 144: 296-301, 1994.
11. Rotter V, Aloni-Grinstein R, Schwartz D, Elkind NB, Somons A, Wolkowicz R, Lavigne M, Beserman P, Kapon A and Goldfinger N: Does wild-type p53 play a role in normal cell differentiation? Cancer Biol 5: 229-236, 1994.
12. Spandau DF: Distinct conformation of p53 are observed at different stages of keratinocyte differentiation. Oncogene 9: 1861-1868, 1994.
13. Brambilla E, Gazzeri S, Moro D, Caron de Fromentel C, Gouyer V, Jacrot M and Brambilla C: Immunohistochemical study of p53 in human lung carcinomas. Am J Pathol 143: 199-210, 1993.
14. Bennett W, Colby T, Travis W, Borkowski A, Jones RT, Lane DP, Metcalf RA, Samet JM, Takeshima Y, Gu JR, Vahakangas KH, Soini Y, Paakko P, Welsh JA, Trump BF and Harris CC: P53 protein accumulation frequently in early bronchial neoplasia. Cancer Res 53: 4817-4822, 1993.
15. Westra WH, Offerhaus GJA, Goodman SN, Slebos RJC, Polak M, Baas IO, Rodenhuis S and Hruban HR: Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking. Am J Surg Pathol 17: 213-220, 1993.
16. McLaren R, Kuzu I, Dunnill M, Harris A, Lane D and Garter CK: The relationship of p53 immunostaining to survival in carcinoma of the lung. Br J Cancer 66: 735-738, 1992.
17. World Health Organization: The histological typing of lung tumors. Am J Clin Pathol 77: 123-136, 1982.
18. Hsu SM, Raine L, Fanger H,et al: The use of avidin-biotin-peroxidase complex in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody PAP procedures. J Histochem Cytochem 29: 577-580, 1981.
19. Iggo R, Gatter K, Bartek, Lane D and Haris AL: Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 355: 675-79, 1990.
20. Kandioler D, Foedinger M, Mueller MR, Eckersberger F, Mannhalter C and Wolner E: Carcinogen specific mutation in the p53 tumour suppressor gene in lung cancer. Cardiovasc Surg 107: 1095-1098, 1994.
21. Kerr MK, Carey AF, King G and Lamb D: Atypical alveolar hyperplasia: Relationship with pulmonary adenocarcinoma, p53 and c-erb-B2 expression. J Pathol 174: 249-256, 1994.
22. Passlick B, Izbicki JR, Haussinger K, Thetter O and Pantel K: Immunohistochemical detection of p53 protein is not associated with a poor prognosis in non small-cell lung cancer. J Thorac Cardiovasc Surg 109: 1205-1211 1995.
23. Liloglou T, Ross H, Prime W, Donnelly RJ, Spandidos DA, Gosney JR and Field JK: p53 gene aberrations in non-small-cell lung carcinomas from a smoking population. Br J Cancer 75: 1119-1124, 1997.
24. Kashii T, Mizushima Y, Lima C, Noto H, Sato H, Kusajima Y, Kitagawa M, Sugiyama S and Kobayashi M: Evaluation of prognostic significance of p53 gene alterations in patients with surgically resected lung cancer. Int J Oncol 6: 123-128, 1995.
25. Klein N, Vignaud JM, Sadmi M, Plenat F, Borelly J, Duprez A, Martinet Y and Martinet N: Squamous metaplasia expression of proto-oncogenes and p53 in lung cancer patients. Lab Invest 68: 26-32, 1993.
26. Sozzi G, Miozzo M, Pastorino U, Pilotti S, Donghi R, Giarole M, Gregorio L, Manenti G, Radice P, Minoletti F, Della Porta G and Pierotti AM: Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res 55: 135-140, 1995.
27. Slaughter DP, Southwick HW and Smejkal W: Field cancerization in oral stratifield squamous epithelium. Cancer 6: 693-698, 1953.
28. Nees M, Homann N, Discher H, Andl T, Enders C, Harold-Mende C, Schuhmann A and Bosch XF: Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: A possible molecular basis for the development of multiple tumors. Anticancer Res 25: 4189-4196, 1993.
29. Boers JE, Ten Velde GPM and Thunnissen FB: p53 in squamous metaplasia: A marker for risk of respiratory tract carcinoma. Am J Respir Crit Care Med 153: 411-416, 1996.
30. Nuorva K, Soini Y, Kamel D, Autio-Harmainen H, Risteli L, Risteli C, Vahakangas K and Paakko P: Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas. Am J Pathol 142: 725-732, 1993.
31. Sozzi G, Miozzo M, Donghi R, Pilotti S, Cariani CT, Pastorino U, Porta GD and Pierotti AM: Deletion of 17p and p53 mutation in preneoplastic lesions of the lung. Cancer Res 52: 6079-6082, 1992.
32. Pavelic ZP, Gluckman JL, Gapany M, Reising J, Craven JM, Kelley DJ, Pavelic L, Gapany S, Biddinger P and Stambrook JP: Improved immunohistochemical detection of p53 protein in paraffin-embedded tissues reveals elevated levels in most head and neck and lung carcinomas: Correlation with clinicopathological parameters. Anticancer Res 12: 1389-1394, 1992.
33. Casson AG, McCuuaig S, Craig I, Ayed A, Inculet R, Kekvliet N and O'Malley F: Prognostic value and clinicopathologic correlation of p53 gene mutations and nuclear DNA content in human lung cancer: A prospective study. J Surg Oncol 56: 13-20, 1994.
34. Lee L, Shew J, Sheu J, Lee YC, Lee WC, Fang MT, Chang HF, Yu CJ, Yang PC and Luh KT: Exon 8 mutation of p53 gene associated with nodal metastasis in non-small-cell lung cancer. Am J Respir Crit Care Med 150: 1667-1671, 1994.
35. Papadakis E, Malliri A, Linardopoulos S, Karaiossifidi H, Field JK and Spandidos DA: Ras and p53 expression in non-small cell lung cancer patients: p53 over-expression correlates with a poor prognosis. Int J Oncol 1: 403-413, 1992.
36. Gannon JV, Greaves R, Iggo R and Lane D: Activating mutations in p53 produce a common conformation effect. EMBO J 9: 1595-1602, 1990.
37. Kalthoff H, Schmiegel W, Roeder C, Kasche D, Schmidt A, Lauer G, Thiele HG, Honold G, Pantel K, Riethmuller G, Scherer E, Maurer J, Maacke H and Deppert W: P53 and K-RAS alterations in pancreatic epithelial cell lesions. Oncogene 8: 298-298, 1993.
38. Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Bleehen NM and Rabbitts P: P53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in pre-invasive lesions of the bronchus. Oncogene 7: 1989-1997, 1992.
39. Deitos A, Doglioni C, Laurino L, Barbareschi M and Fletcher CDM: P53 protein expression in non-neoplastic lesions and benign and malignant neoplasms of soft tissue. Histopatholoay 22: 45-50, 1993.
40. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991.
41. Momand J, Zambetti GP, Oslon CD, George D and Levine JA: The mdm2 oncogene product forms a complex with the p53 protein and inhibits p53 mediated transactivation. Cell 69: 1237-1245, 1992.
42. Marchetti A, Buttitta F, Pellegrini S, Merlo G, Chella A, Angeletti CA and Bevilacqua G: MDM2 gene amplification and overexpression in non-small cell lung carcinomas with accumulation of the p53 protein in the absence of p53 gene mutation. Diagn Mol Pathol 4: 93-97, 1995.
43. Gusterson BA, Anbazhagan R, Warren W, Midgely C, Lane DP, O'Hare M, Stamps A, Carter R and Jayatilake H: Expression of p53 in premalignant and malignant squamous epithelium. Oncogene 6: 1785-1789, 1991.